| scholarly article | Q13442814 |
| P50 | author | Matthias Mörgelin | Q28805358 |
| Phillip I Tarr | Q89654715 | ||
| Diana Karpman | Q42887742 | ||
| P2093 | author name string | Catharina Svanborg | |
| Roger Johnson | |||
| Sandra L Watkins | |||
| Jody C Mooney | |||
| Majlis Svensson | |||
| Anne-lie Ståhl | |||
| P2860 | cites work | Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene | Q22299417 |
| Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor | Q24317407 | ||
| Structure and function of lipopolysaccharide binding protein | Q24324774 | ||
| Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function | Q24538771 | ||
| Toll-like receptors in the induction of the innate immune response | Q28144797 | ||
| Shiga toxin binds to activated platelets | Q30312261 | ||
| Shiga toxin 2 and lipopolysaccharide cause monocytic THP-1 cells to release factors which activate platelet function | Q30439001 | ||
| Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome. | Q33337242 | ||
| Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome. | Q33338331 | ||
| Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms | Q33340303 | ||
| Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome | Q33340490 | ||
| Endotoxin enhances microvascular thrombosis in mouse cremaster venules via a TLR4-dependent, neutrophil-independent mechanism | Q81472583 | ||
| Escherichia coli O157 fails to induce a long-lasting lipopolysaccharide-specific, measurable humoral immune response in children with hemolytic-uremic syndrome | Q33343901 | ||
| Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. | Q33363208 | ||
| Platelets express functional Toll-like receptor-4. | Q33366814 | ||
| Hemolytic-uremic syndrome and Vero cytotoxin-producing Escherichia coli infection in Italy. The HUS Italian Study Group | Q33367628 | ||
| Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo | Q33368585 | ||
| Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes | Q33397981 | ||
| The relationship between plasma levels of the factor VIII complex and platelet release products (beta-thromboglobulin and platelet factor 4) in children with the hemolytic-uremic syndrome | Q33476001 | ||
| Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes | Q33478268 | ||
| Soluble P‐selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome | Q33489289 | ||
| The fibrinolytic system in the hemolytic uremic syndrome: in vivo and in vitro studies | Q33491213 | ||
| Impaired fibrinolysis in the hemolytic-uremic syndrome of childhood | Q33492255 | ||
| Platelet-derived microvesicles in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. | Q33496239 | ||
| Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid | Q33503400 | ||
| Evolution of genomic content in the stepwise emergence of Escherichia coli O157:H7. | Q33714500 | ||
| Biocontrol of Escherichia coli O157 with O157-specific bacteriophages | Q34012025 | ||
| Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14 | Q36197092 | ||
| Structure of the O-chain polysaccharide of the phenol-phase soluble lipopolysaccharide of Escherichia coli 0:157:H7. | Q36424890 | ||
| Independent trafficking of Ig-alpha/Ig-beta and mu-heavy chain is facilitated by dissociation of the B cell antigen receptor complex | Q37492524 | ||
| Biphasic, organ-specific, and strain-specific accumulation of platelets induced in mice by a lipopolysaccharide from Escherichia coli and its possible involvement in shock | Q39826933 | ||
| Interaction of endotoxic lipid A and lipid X with purified human platelet protein kinase C. | Q41222565 | ||
| Endotoxic lipid A induces intracellular Ca2+ increase in human platelets | Q42133553 | ||
| Increased circulating levels of lipopolysaccharide binding protein in children with Escherichia coli O157:H7 hemorrhagic colitis and hemolytic uremic syndrome | Q42735080 | ||
| Enteropathogens in adult patients with diarrhea and healthy control subjects: a 1-year prospective study in a Swedish clinic for infectious diseases | Q50121060 | ||
| Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. | Q52034506 | ||
| CD14-dependent and CD14-independent signaling pathways in murine macrophages from normal and CD14 knockout mice stimulated with lipopolysaccharide or taxol. | Q52525157 | ||
| A study on rat platelet responsiveness following intravenous endotoxin administration. | Q54574656 | ||
| Studies of fibrinogen binding to platelets by flow cytometry: an improved method for studies of platelet activation | Q67913695 | ||
| Design and construction of a linear shear stress flow chamber | Q70564668 | ||
| Electrophoretic heterogeneity and interstrain variation of the lipopolysaccharide of Haemophilus influenzae | Q70994056 | ||
| Platelet accumulation induced by bacterial endotoxin in rats | Q71713160 | ||
| Stimulatory effects of endotoxin on the platelet secretory process | Q73330713 | ||
| Immunoneutralization of glycoprotein Ibalpha attenuates endotoxin-induced interactions of platelets and leukocytes with rat venular endothelium in vivo | Q73825675 | ||
| Response of blood platelets to Proteus mirabilis lipopolysaccharide | Q74392473 | ||
| P-selectin binds to bacterial lipopolysaccharide | Q74442096 | ||
| Adhesion of thrombin-stimulated and unstimulated blood platelets to collagen in the presence of Proteus mirabilis lipopolysaccharides | Q77510552 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell biology | Q7141 |
| Escherichia coli | Q25419 | ||
| patient | Q181600 | ||
| toll like receptor 4 | Q2335493 | ||
| selectin P | Q4046137 | ||
| toll-like receptor | Q408004 | ||
| lipopolysaccharide | Q421804 | ||
| defense response to Gram-negative bacterium | Q14865229 | ||
| Selectin, platelet | Q14881076 | ||
| Toll-like receptor 4 | Q14914104 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 167-176 | |
| P577 | publication date | 2006-03-02 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome | |
| P478 | volume | 108 |
| Q35125841 | A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesicles |
| Q33373698 | ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpura |
| Q33420374 | Activation of the alternative pathway of complement during the acute phase of typical haemolytic uraemic syndrome. |
| Q27026551 | Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infection |
| Q33420958 | Association of haemolytic uraemic syndrome with dysregulation of chemokine receptor expression in circulating monocytes |
| Q38053703 | Bovine innate and adaptive immune responses against Escherichia coli O157:H7 and vaccination strategies to reduce faecal shedding in ruminants |
| Q34204639 | Calpain activity and Toll-like receptor 4 expression in platelet regulate haemostatic situation in patients undergoing cardiac surgery and coagulation in mice. |
| Q91895067 | Canine platelets express functional Toll-like receptor-4: lipopolysaccharide-triggered platelet activation is dependent on adenosine diphosphate and thromboxane A2 in dogs |
| Q27302075 | Capture of lipopolysaccharide (endotoxin) by the blood clot: a comparative study |
| Q57702450 | Chapter 14 Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic Purpura |
| Q33425421 | Complement Interactions with Blood Cells, Endothelial Cells and Microvesicles in Thrombotic and Inflammatory Conditions |
| Q28390993 | Down-regulation of platelet surface CD47 expression in Escherichia coli O157:H7 infection-induced thrombocytopenia |
| Q92857675 | Early Host Interactions That Drive the Dysregulated Response in Sepsis |
| Q34889826 | Effects of Shiga toxin type 2 on a bioengineered three-dimensional model of human renal tissue |
| Q33436437 | Effects of Suilysin on Streptococcus suis-Induced Platelet Aggregation |
| Q44419623 | Efficient phagocytosis of periodontopathogens by neutrophils requires plasma factors, platelets and TLR2. |
| Q27016553 | Emerging roles for platelets as immune and inflammatory cells |
| Q38897447 | Endotoxemia-menace, marker, or mistake? |
| Q33394010 | Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease |
| Q33428410 | Escherichia coli induces platelet aggregation in an FcγRIIa-dependent manner |
| Q33419814 | Expression and functionality of Toll-like receptor 3 in the megakaryocytic lineage |
| Q30244707 | Haemolytic uraemic syndrome |
| Q40736860 | Human platelet activation by Escherichia coli: roles for FcγRIIA and integrin αIIbβ3. |
| Q54377737 | Immunomodulating Activity of Lactobacillus paracasei subsp. paracasei NTU 101 in Enterohemorrhagic Escherichia coli O157H7-Infected Mice |
| Q58577394 | Impact of Escherichia coli K12 and O18:K1 on human platelets: Differential effects on platelet activation, RNAs and proteins |
| Q27692706 | Inflammasome in platelets: allying coagulation and inflammation in infectious and sterile diseases? |
| Q42248441 | Lipopolysaccharide is a direct agonist for platelet RNA splicing |
| Q33952458 | Lipopolysaccharide renders transgenic mice expressing human serum amyloid P component sensitive to Shiga toxin 2 |
| Q33384817 | Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway |
| Q37281999 | Lipopolysaccharide stimulates platelets through an IL-1β autocrine loop |
| Q33404149 | Management of Shiga toxin-associated Escherichia coli-induced haemolytic uraemic syndrome: randomized clinical trials are needed |
| Q47127903 | Microvesicle Involvement in Shiga Toxin-Associated Infection |
| Q54453232 | Passive immunity acquisition of maternal anti-enterohemorrhagic Escherichia coli (EHEC) O157:H7 IgG antibodies by the newborn. |
| Q39096310 | Phylogeny and phenotypes of clinical and environmental Shiga toxin-producing Escherichia coli O174. |
| Q89169483 | Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases |
| Q35990633 | Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin |
| Q43706324 | Platelet immunology and the immune response |
| Q38390429 | Platelet interaction with bacterial toxins and secreted products |
| Q38362628 | Platelet transfusion - the new immunology of an old therapy |
| Q37678953 | Platelet-bacterial interactions. |
| Q38017397 | Platelets and cytokines: How and why? |
| Q35124418 | Platelets and infections - complex interactions with bacteria. |
| Q37657202 | Platelets and innate immunity |
| Q37857647 | Platelets and the immune continuum |
| Q37081746 | Platelets as cellular effectors of inflammation in vascular diseases |
| Q34590168 | Platelets as immune mediators: Their role in host defense responses and sepsis |
| Q57676581 | Platelets as immune-sensing cells |
| Q55004062 | Platelets in Immune Response to Virus and Immunopathology of Viral Infections. |
| Q26739670 | Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases |
| Q90458246 | Platelets modulate multiple markers of neutrophil function in response to in vitro Toll-like receptor stimulation |
| Q57653563 | Platelets regulate leucocyte responses to Toll-like receptor stimulation |
| Q35101184 | Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum |
| Q35037420 | Regulatory effects of TLR2 on megakaryocytic cell function |
| Q46642629 | Role of Perinatal Inflammation in Neonatal Arterial Ischemic Stroke |
| Q98290004 | Role of platelet biomarkers in inflammatory response |
| Q33386199 | Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome |
| Q33397541 | Shiga toxin pathogenesis: kidney complications and renal failure |
| Q47321222 | Shiga toxin triggers endothelial and podocyte injury: the role of complement activation |
| Q33389321 | Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction |
| Q30439707 | Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7. |
| Q90511412 | Start a fire, kill the bug: The role of platelets in inflammation and infection |
| Q42137745 | Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase |
| Q40457723 | Suilysin-induced Platelet-Neutrophil Complexes Formation is Triggered by Pore Formation-dependent Calcium Influx. |
| Q90401541 | The Era of Thromboinflammation: Platelets Are Dynamic Sensors and Effector Cells During Infectious Diseases |
| Q27004467 | The Inflammatory Role of Platelets via Their TLRs and Siglec Receptors |
| Q93092336 | The Role of Human Platelet Preparation for Toll-Like Receptors 2 and 4 Related Platelet Responsiveness |
| Q38367124 | The expanding field of platelet-bacterial interconnections |
| Q39256913 | The long polar fimbriae of STEC O157:H7 induce expression of pro-inflammatory markers by intestinal epithelial cells. |
| Q33413094 | The role of calpain-myosin 9-Rab7b pathway in mediating the expression of Toll-like receptor 4 in platelets: a novel mechanism involved in α-granules trafficking |
| Q37640684 | The role of inflammation in regulating platelet production and function: Toll-like receptors in platelets and megakaryocytes |
| Q37869349 | The thrombotic potential of oral pathogens |
| Q34316343 | Thrombosis as an intravascular effector of innate immunity |
| Q47147432 | Toll-Like Receptor 4 Signalling and Its Impact on Platelet Function, Thrombosis, and Haemostasis. |
| Q36038084 | Toll-Like Receptor Signalling Is Not Involved in Platelet Response to Streptococcus pneumoniae In Vitro or In Vivo |
| Q33397459 | Toll-like receptor 4 expression on circulating leucocytes in hemolytic uremic syndrome |
| Q34734986 | Toll-like receptor 4 regulates platelet function and contributes to coagulation abnormality and organ injury in hemorrhagic shock and resuscitation |
| Q50115928 | Translational Implications of Platelets as Vascular First Responders |
| Q82239801 | [Platelets "Toll-like receptor" engagement stimulates the release of immunomodulating molecules] |
| Q64960314 | [Platelets cytokines and their effects on platelet transfusion]. |
Search more.